Michael Bogart
Overview
Explore the profile of Michael Bogart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singer D, Thompson-Leduc P, Ma S, Gupta D, Cheng W, Muthukumar A, et al.
BMJ Open Respir Res
. 2024 Jun;
11(1).
PMID: 38862238
Background: Herpes zoster (HZ) is a painful condition caused by reactivation of the varicella-zoster virus. The objectives of this study were to compare HZ incidence in adults with asthma versus...
2.
Bogart M, Leung G, Cyhaniuk A, DiRocco K
Int J Chron Obstruct Pulmon Dis
. 2024 Feb;
19:439-450.
PMID: 38374817
Purpose: Patients with chronic obstructive pulmonary disease (COPD) who are hospitalized are more likely to die from their illness and have increased likelihood of re-admission than those who are not....
3.
Bogart M, Bengtson L, Johnson M, Bunner S, Gronroos N, DiRocco K
Int J Chron Obstruct Pulmon Dis
. 2024 Jan;
19:97-110.
PMID: 38226396
Purpose: Patients with chronic obstructive pulmonary disease (COPD) have been shown to benefit from triple therapy commonly delivered by multiple-inhaler triple therapy (MITT); however, the complexity of MITT regimens may...
4.
Bogart M, Germain G, Laliberte F, Mahendran M, Duh M, DiRocco K, et al.
J Asthma Allergy
. 2023 Dec;
16:1309-1322.
PMID: 38058516
Purpose: Real-world asthma control data among patients initiating fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) are limited. This study assessed rescue medication use and asthma-related exacerbations in patients with asthma before and after initiating...
5.
Bogart M, Abbott C, Bangalore M, McMorrow D, Packnett E, DiRocco K
Int J Chron Obstruct Pulmon Dis
. 2023 Nov;
18:2367-2379.
PMID: 37933243
Purpose: Oral corticosteroids (OCS) play a role in the treatment of acute chronic obstructive pulmonary disease (COPD) exacerbations; however, chronic use is not recommended due to the high rate of...
6.
Silver J, Deb A, Packnett E, McMorrow D, Morrow C, Bogart M
J Clin Rheumatol
. 2023 Oct;
29(8):381-387.
PMID: 37779234
Background/objective: Although the high disease burden associated with eosinophilic granulomatosis with polyangiitis (EGPA) has been established, the disease burden in patients initiating mepolizumab in real-world practice is poorly understood. This...
7.
Perwaiz M, Durrance R, Bogart M, Obata R, Bradley E
Ann Med Surg (Lond)
. 2023 Sep;
85(9):4201-4205.
PMID: 37663684
Background: The COVID-19 pandemic has exponentially expanded the number of patients requiring treatment for chronic respiratory failure. One consequence is an increase in the number of patients requiring intubation and...
8.
Bogart M, Germain G, Laliberte F, Lejeune D, Duh M
Int J Chron Obstruct Pulmon Dis
. 2023 Jul;
18:1575-1586.
PMID: 37521022
Purpose: There is limited literature regarding real-world treatment patterns of patients with COPD, particularly since the introduction of once-daily single-inhaler triple therapy with fluticasone furoate/umeclidinium/vilanterol in 2017. Here, we evaluated...
9.
Hanania N, Bunner S, Bengtson L, Ismaila A, Bogart M
Int J Chron Obstruct Pulmon Dis
. 2023 Mar;
18:407-418.
PMID: 36998390
Purpose: To examine the impact of initiating fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) in a single device on chronic obstructive pulmonary disease (COPD) exacerbations, COPD exacerbation-related costs, and all-cause and COPD-related healthcare resource...
10.
Thompson-Leduc P, Ghaswalla P, Cheng W, Wang M, Bogart M, Patterson B, et al.
Clin Respir J
. 2022 Nov;
16(12):826-834.
PMID: 36415956
Chronic obstructive pulmonary disease (COPD) has been reported as a potential risk factor for developing herpes zoster (HZ). We aimed at comparing incidence rates of HZ between people with versus...